Onyekwere Charles Asabamaka, O Ogbera Anthonia, Olusola Dada Akinola, O Adeleye Olufunke, O Dosunmu Adedoyin, Akinbami Akinsegun A, Osikomaiya Bodunrin, Hameed Oladipupo
Department of Medicine, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.
Department of Medicine, Ogun State University Medical School, Ago-Iwoye, Nigeria.
Hepat Mon. 2016 May 1;16(5):e35532. doi: 10.5812/hepatmon.35532. eCollection 2016 May.
With the advent of highly effective anti-hepatitis C virus (HCV) drugs, efforts to identify infected cases, high-risk groups, and associated risk factors have become the focus of current control measures.
To determine the prevalence of the HCV antibody among diabetics and patients with lymphoproliferative disorders (LPD) who presented to the outpatient clinics of a university hospital and its associated risk factors.
Consecutively consenting patients who had been previously diagnosed with diabetes mellitus and LPD at the outpatient department of the Lagos State University teaching hospital were recruited. A case record form was used to extract their demographics and physical examination findings as well as any risk factors for HCV infection; blood was also drawn to run a serological assay for the HCV antibody. All data were collated and analyzed using the Statistical Package for the Social Sciences version 20. Student T-test, Chi square, and logistic regression were some of the inferential statistics used in addition to descriptive statistics.
In all, 438 patients (405 diabetics and 33 patients with LPD) were recruited. Their ages ranged from 17 - 87 years with a mean + Standard deviation of 59.61 + 11.859 years. The prevalence of hepatitis C among the diabetic subgroup was 0.7%, while the antibody was present in 9.1% of the LPD patients. The occurrence of the HCV antibody was, however, not significantly associated with age, sex, educational level, or marital status (P > 0.05). Having multiple sexual partners was identified as the only significant risk factor for hepatitis C (OR = 9.148; P = 0.017).
This survey suggested that a higher HCV prevalence exists in this population than is currently reported in the general population, and having sex with multiple partners was a risk factor for HCV infection.
随着高效抗丙型肝炎病毒(HCV)药物的出现,识别感染病例、高危人群及相关危险因素的工作已成为当前防控措施的重点。
确定在某大学医院门诊就诊的糖尿病患者和淋巴增殖性疾病(LPD)患者中HCV抗体的流行情况及其相关危险因素。
连续招募此前在拉各斯州立大学教学医院门诊被诊断为糖尿病和LPD的自愿参与患者。使用病例记录表提取他们的人口统计学信息、体格检查结果以及任何HCV感染的危险因素;同时采集血液进行HCV抗体血清学检测。所有数据使用社会科学统计软件包第20版进行整理和分析。除描述性统计外,还使用了学生t检验、卡方检验和逻辑回归等一些推断性统计方法。
共招募了438名患者(405名糖尿病患者和33名LPD患者)。他们的年龄在17至87岁之间,平均年龄+标准差为59.61 + 11.859岁。糖尿病亚组中丙型肝炎的患病率为0.7%,而LPD患者中有9.1%存在抗体。然而,HCV抗体的出现与年龄、性别、教育程度或婚姻状况均无显著关联(P > 0.05)。有多个性伴侣被确定为丙型肝炎的唯一显著危险因素(OR = 9.148;P = 0.017)。
这项调查表明,该人群中HCV患病率高于目前一般人群的报告水平,与多个性伴侣发生性行为是HCV感染的一个危险因素。